Laurion Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-150,000
| Closed | -$11.3M | – | 337 |
|
|
2025
Q3 | $11.3M | Buy |
+150,000
| New | +$10.3M | 0.19% | 91 |
|
|
2024
Q2 | – | Sell |
-150,100
| Closed | -$12M | – | 603 |
|
|
2024
Q1 | $12M | Buy |
+150,100
| New | +$11.5M | 0.1% | 172 |
|
|
2023
Q1 | – | Sell |
-175,000
| Closed | -$16.3M | – | 450 |
|
|
2022
Q4 | $16.3M | Buy |
+175,000
| New | +$16.9M | 0.08% | 189 |
|
|
2021
Q4 | – | Sell |
-423,200
| Closed | -$35.9M | – | 589 |
|
|
2021
Q3 | $35.9M | Buy |
423,200
+362,200
| +594% | +$30.3M | 0.15% | 144 |
|
|
2021
Q2 | $5.09M | Buy |
+61,000
| New | +$5M | 0.03% | 277 |
|
|
2020
Q4 | – | Sell |
-27,400
| Closed | -$1.6M | – | 692 |
|
|
2020
Q3 | $1.6M | Sell |
27,400
-158,300
| -85% | -$9.85M | 0.02% | 343 |
|
|
2020
Q2 | $12.1M | Buy |
185,700
+126,100
| +212% | +$7.94M | 0.14% | 163 |
|
|
2020
Q1 | $3.54M | Sell |
59,600
-136,200
| -70% | -$9.09M | 0.04% | 285 |
|
|
2019
Q4 | $14.5M | Buy |
+195,800
| New | +$13.7M | 0.11% | 177 |
|
|
2019
Q3 | – | Sell |
-388,000
| Closed | -$21.1M | – | 1065 |
|
|
2019
Q2 | $21.1M | Buy |
+388,000
| New | +$20.9M | 0.21% | 113 |
|
|
2018
Q4 | – | Sell |
-143,800
| Closed | -$11.3M | – | 1164 |
|
|
2018
Q3 | $11.3M | Buy |
+143,800
| New | +$10.3M | 0.11% | 207 |
|
|
2017
Q4 | – | Sell |
-84,600
| Closed | -$6.88M | – | 1584 |
|
|
2017
Q3 | $6.88M | Sell |
84,600
-63,400
| -43% | -$5.02M | 0.03% | 415 |
|
|
2017
Q2 | $11.9M | Sell |
148,000
-290,700
| -66% | -$23M | 0.07% | 282 |
|
|
2017
Q1 | $34.4M | Buy |
+438,700
| New | +$35M | 0.26% | 91 |
|
|
2016
Q1 | – | Sell |
-380,000
| Closed | -$37.2M | – | 826 |
|
|
2015
Q4 | $37.2M | Buy |
+380,000
| New | +$37.2M | 0.34% | 66 |
|
|
2015
Q3 | – | Sell |
-150,000
| Closed | -$15.7M | – | 757 |
|
|
2015
Q2 | $15.7M | Sell |
150,000
-250,000
| -63% | -$25.5M | 0.14% | 172 |
|
|
2015
Q1 | $41.3M | Buy |
+400,000
| New | +$40.5M | 0.8% | 34 |
|
|
2014
Q4 | – | Sell |
-230,000
| Closed | -$18.3M | – | 330 |
|
|
2014
Q3 | $18.3M | Buy |
+230,000
| New | +$18.1M | 0.39% | 68 |
|
|
2014
Q2 | – | Sell |
-200,000
| Closed | -$15M | – | 293 |
|
|
2014
Q1 | $15M | Buy |
200,000
+140,800
| +238% | +$9.95M | 0.55% | 73 |
|
|
2013
Q4 | $4.24M | Sell |
59,200
-68,700
| -54% | -$4.41M | 0.14% | 77 |
|
|
2013
Q3 | $7.26M | Buy |
127,900
+76,200
| +147% | +$4.54M | 0.54% | 47 |
|
|
2013
Q2 | $2.96M | Buy |
+51,700
| New | +$3M | 0.18% | 90 |
|
Other funds holding CVS
Laurion Capital Management's CVS Position: Q3 2025 in Review
Laurion Capital Management sold out of CVS Health (CVS) in Q3 2025, closing a stake of 3,201 shares — an estimated $219K sold.
Laurion Capital Management first reported a position in CVS in Q4 2014 and held it in 24 quarters. The position peaked at $96M in Q1 2024. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.
- Laurion Capital Management reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
- Laurion Capital Management sold 3,201 CVS Health shares in Q3 2025, an estimated $219K.
- Laurion Capital Management first reported a position in CVS Health in Q4 2014 and held it in 24 quarters.
- Laurion Capital Management's CVS Health position peaked at $96M in Q1 2024.
- 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.
Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.